Nom original: reférences.pdf
Ce document au format PDF 1.4 a été généré par Writer / LibreOffice 3.6, et a été envoyé sur fichier-pdf.fr le 23/10/2014 à 20:00, depuis l'adresse IP 82.244.x.x.
La présente page de téléchargement du fichier a été vue 629 fois.
Taille du document: 65 Ko (2 pages).
Confidentialité: fichier public
Aperçu du document
Ahmetov et al. (2009) The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet.;126(6):751-61.
Ahmetov et al. (2008) The use of molecular genetic methods for prognosis of aerobic and anaerobic performance in athletes. Human Physiology; Volume 34, Issue 3, pp 338-342.
Ahmetov et al. (2006) PPARα gene variation and physical performance in Russian athletes. European Journal of Applied Physiology; Volume 97, Issue 1, pp 103-108.
Andrulionyte et al. (2007) Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance
to type 2 diabetes: the STOP-NIDDM trial. Diabetes.;56(4):1181-6.
Andrulionyte et al. (2004) Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose
tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia.;47(12):2176-84.
Arany et al. (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 21;451(7181):1008-12.
Archer et al. (2003) A Length Polymorphism in the Circadian Clock Gene Per3 is Linked to Delayed Sleep Phase Syndrome and Extreme Diurnal Preference. SLEEP, Vol. 26, No. 4.
Astrup et al. (1999) Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation. Int J Obes Relat Metab Disord.;23(10):1030-4.
Boivin et al. (2000) Uncoupling Protein-2 and -3 Messenger Ribonucleic Acids in Adipose Tissue and Skeletal Muscle of Healthy Males: Variability, Factors Affecting Expression, and
Relation to Measures of Metabolic Rate. The Journal of Clinical Endocrinology & Metabolism; vol. 85 no. 5 1975-1983.
Boström et al (2012) A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature.;481(7382):463-8.
Bouchard et al. (1997) Linkage Between Markers in the Vicinity of the Uncoupling Protein 2 Gene and Resting Metabolic Rate in Humans. Hum. Mol. Genet. 6 (11): 1887-1889.
Bouchard, C., & Shephard, R.J. (1994). Physical activity, fitness and health: The model and key concepts. In C. Bouchard, R.J. Shephard, & T. Stephens (eds.), Physical activity, fitness
and health: International proceedings and consensus statement (pp. 11-20). Champaign, IL: Human Kinetics Publishers.
Broos et al. (2011) Is PPARα intron 7 G/C polymorphism associated with muscle strength characteristics in nonathletic young men? Scand J Med Sci Sports. Oct 30;: 22092351
Buemann et al. (2001) The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency. Int J Obes Relat Metab Disord. Apr;25(4):467-71.
Cam et al (2007) ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort. J Sports Med Phys Fitness; 47(2):234-8.
Charbonneau et al. (2008) ACE Genotype and the Muscle Hypertrophic and Strength Responses to Strength Training. Med Sci Sports Exerc. 40(4): 677–683.
Collins et al. (2004) The ACE gene and endurance performance during the South African Ironman Triathlons. Med Sci Sports Exerc. Aug;36(8):1314- 20.
Clarkson et al. (2005) ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol. Jul;99(1):154-63.
Ellis et al. (2009) Association between Specific Diurnal Preference Questionnaire Items and PER3 VNTR Genotype. Chronobiol Int. Apr;26(3):464-73.
Esterbauer et al. (2001) A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet.;28(2):178-83.
Eynon et al. (2013) Genes for Elite Power and Sprint Performance: ACTN3 Leads the Way. Sports Med. May [epub ahead of print].
Eynon et al. (2010) Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Scand J Med Sci Sports;20(1):e145-50.
Finck and Kelly (2006) PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest.; 116(3): 615–622.
Flavell et al. (2005) Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes. Diabetes. 54(2):582-6.
Folland et al. (2000) Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol. 2000 Sep;85(5):575-9.
Franks et al. (2003) PGC-1alpha genotype modifies the association of volitional energy expenditure with VO2max. Med Sci Sports Exerc.;35(12):1998-2004.
Gayagay et al. (1998) Elite endurance athletes and the ACE I allele--the role of genes in athletic performance. Hum Genet. Jul; 103(1):48-50.
Geisterfer et al (1988) Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circulation Research.; 62: 749-756
Giaccaglia et al. (2008) Interaction between angiotensin converting enzyme insertion/deletion genotype and exercise training on knee extensor strength in older individuals. Int J Sports
Ginevičienė et al. (2010) Relating fitness phenotypes to genotypes in Lithuanian elite athletes. Acta medica Lituanica. Volume 17, Number 1 – 2.
Guess et al. (2009) Circadian disruption, Per3, and human cytokine secretion. Integr Cancer Ther.;8(4):329-36.
Häkkinen et al (1998) Changes in muscle morphology, electromyographic activity, and force production characteristics during progressive strength training in young and older men. J
Gerontol A Biol Sci Med Sci.;53(6):B415-23.
Handschin and Spigelman (2008) The role of exercise and PGC1alpha in inflammation and chronic disease. Nature.;454(7203):463-9.
Handschin and Spiegelman (2006) Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev.;27(7):728-35.
Horowitz et al. (2000) Effect of endurance training on lipid metabolism in women: a potential role for PPARα in the metabolic response to training. AJP – Endo; vol. 279 no. 2 E348-E355.
Huh et al. (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight
loss and exercise. Metabolism.; 61(12):1725-38.
Jamshidi et al (2002) Peroxisome proliferator-- activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation. 26;105(8):950-5.
Kai et al. (1998) Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice. J Hypertens.;16(12 Pt 2):2045-9.
Kang and Ji (2013) Role of PGC-1a in muscle function and aging. Journal of Sport and Health Science, Vol. 2 Issue (2): 81-86.
Kovacs et al. (2005) Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians. Diabetologia. 48(11):2292-5.
Kunorozva et al. (2012) Chronotype and PERIOD3 variable number tandem repeat polymorphism in individual sports athletes. Chronobiol Int; 29(8):1004- 10.
Lin et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature; 418(6899):797-801.
Ling et al. (2004) Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1α gene expression in twins. J Clin Invest; 114(10): 1518–1526.
Lucia et al. (2005) PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol; 99(1):344-8.
Ma F, Yang Y, Li X, Zhou F, Gao C, et al. (2013) The Association of Sport Performance with ACE and ACTN3 Genetic Polymorphisms: A Systematic Review and Meta-Analysis. PLoS
ONE 8(1): e54685.
Maciejewska et al (2012) The PPARGC1A gene Gly482Ser in Polish and Russian athletes. J Sports Sci; 30(1):101-13.
Maciejewska et al (2011) Variation in the PPARα gene in Polish rowers. J Sci Med Sport. 2011 Jan;14(1):58- 64.
Montgomery et al. (1998) Human gene for physical performance. Nature 393, 221-222
Myerson et al. (1999) Human angiotensin I-converting enzyme gene and endurance performance. Journal of Applied Physiology; vol. 87 no. 4 1313-1316
Norman et al. (2009) Strength, power, fiber types, and mRNA expression in trained men and women with different ACTN3 R577X genotypes. J Appl Physiol.;106(3):959-65.
North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, Beggs AH (1999) A common nonsense mutation results in α-actinin-3 deficiency in the general population. Nat Genet
Pimenta et al. (2012) The ACTN3 genotype in soccer players in response to acute eccentric training. Eur J Appl Physiol. Apr;112(4):1495-503.
Puthucheary et al (2011) The ACE gene and human performance: 12 years on. Sports Med. 1;41(6):433- 48.
Seto et al. (2011) Deficiency of a-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodelling. Hum Mol Genet; 1;20(15):2914-27.
Souza et al (2011) The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications. Arq Bras Endocrinol Metabol; 55(4):239-48.
Spiegelman and Korsmeyer (2012) Irisin and the therapeutic benefits of exercise. BMC Proceedings; 6 (Suppl 3):O23.
Rattigan et al. (1996) Perfused skeletal muscle contraction and metabolism improved by angiotensin II-mediated vasoconstriction. Am J Physiol, 271(1 Pt 1):E96-103.
Rigat et al. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86(4):1343-6.
Russell et al. (2003) Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome
proliferator-activated receptor-alpha in skeletal muscle. Diabetes. 52(12):2874-81.
St-Pierre et al (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 20;127(2):397- 408.
Venckunas et al. (2012) Human alpha-actinin-3 genotype association with exercise-induced muscle damage and the repeated-bout effect. Applied Physiology, Nutrition, and Metabolism,
Vincent et al. (2010) Protective role of alpha-actinin-3 in the response to an acute eccentric exercise bout. J Appl Physiol. 2010 Aug;109(2):564-73
Vincent et al. (2007) ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol. Genomics; vol. 32 no. 1 58-63.
Viola et al. (2007) PER3 Polymorphism Predicts Sleep Structure and Waking Performance. Current Biology, Volume 17, Issue 7, 613-618.
Wenz et al. (2009) Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A. 1;106(48):20405-10.
Williams et al. (2000) The ACE gene and muscle performance. Nature 403, 614.
Wirth et al. (2013) Association of the Period3 clock gene length polymorphism with salivary cortisol secretion among police officers. Neuro Endocrinol Lett.;34(1):27-37.
Woods et al. (2008) Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet.;108(3):230- 2.
Xiu et al. (2004) Common variants in beta 3-adrenergic-receptor and uncoupling protein-2 genes are associated with type 2 diabetes and obesity. Zhonghua Yi Xue Za Zhi. 2004;84(5):3759.
Yang et al. (2003) ACTN3 Genotype Is Associated with Human Elite Athletic Performance Am J Hum Genet; 73(3): 627–631.
Yu et al. (2005) The uncoupling protein 2 Ala55Val polymorphism is associated with diabetes mellitus: the CARDIA study. Clin Chem. 2005 Aug;51(8):1451-6.
Zhang et al. (2003) The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet.